Clinical Trials Sponsored by Peking University Cancer Hospital and Institute

Total 6863 results

Tianjin Medical University Cancer Institute and...

Unknown

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer

IIIB/IIIC/IV Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

Chemotherapy Effect | Susceptibility, Genetic

China
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer (HST)

Pancreatic Cancer Stage IV | Pancreatic Cancer Stage III

China
Tianjin Medical University Cancer Institute and...

Unknown

A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer

Stage III Esophageal Cancer | Stage II Esophageal Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer (DEBIRI-CRLM)

Colon Cancer Liver Metastasis

China
Tianjin Medical University Cancer Institute and...

Unknown

Phase 2 Trial of Apatinib Mesylate in Locally Advanced/Metastatic Differentiated Thyroid Carcinoma

Differentiated Thyroid Carcinoma

China
Tianjin Medical University Cancer Institute and...

Unknown

Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC) (HCC)

Hepatocellular Carcinoma

China
Tianjin Medical University Cancer Institute and...

Unknown

Study on Effectiveness and Safety of Hepatocellular Carcinoma Patients Treated With CyberKnife

Liver Neoplasms

China
Tianjin Medical University Cancer Institute and...

Unknown

A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer (OECTAPGAMPC)

Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and...

Unknown

Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

A Clinical Trial of Maintenance Treatment of Apatinib in Advanced Gastric Cancer Patients Have Completed Postoprative Adjuvant Chemotherapy

Gastric Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Randomized Study of Concurrent Chemo-radiotherapy vs Radiotherapy Alone to Local-advanced Small Cell Lung Cancer (SCLC) (SCLC)

Small Cell Lung Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.

Metastatic Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and...

Completed

Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia

Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia
Tianjin Medical University Cancer Institute and...

Unknown

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

Metastatic Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer

Metastatic Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy

Esophageal Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer

Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

Breast Diseases

China
Tianjin Medical University Cancer Institute and...

Unknown

Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas (TACE-KMG) (TACE-KMG)

Carcinoma, Hepatocellular

China
Tianjin Medical University Cancer Institute and...

Unknown

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in mCRC

Colorectal Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer

Gastric Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Molecular Phenotype Changes and Personalized Treatment for CRPC

Hormone Refractory Prostate Cancer

China
Tianjin Medical University Cancer Institute and...

Completed

Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

China
Jun Zhu
Peking University First Hospital; Tianjin Medical University Cancer Hospital; Zhejiang Cancer Hospital and other collaborators

Recruiting

China Lymphoma Patient Registry Study (CLAP)

Lymphoma

China
Qilu Pharmaceutical Co., Ltd.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... and other collaborators

Not yet recruiting

Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR

Lung Cancer

China
Beijing Immunochina Medical Science & Technology...
Peking University Cancer Hospital & Institute

Unknown

Assessment of Safety and Efficacy of IM19 for Relapsed or Refractory NHL Patients

Non Hodgkin Lymphoma

China
Cancer Institute and Hospital, Chinese Academy...
Peking University First Hospital; Shanxi Province Cancer Hospital; 307 Hospital... and other collaborators

Unknown

A Hospital Based Survey on Lung Cancer Related-pain in Northern China

Lung Cancer | Cancer Pain
Cancer Institute and Hospital, Chinese Academy...
Zhejiang Cancer Hospital; General Hospital of Chinese Armed Police Forces; Peking... and other collaborators

Unknown

Adjuvant Treatment of Concurrent RT and CAPOX or Capecitabine Alone for Stage II and III Rectal Cancer

Rectal Neoplasms

China
Beijing Friendship Hospital
Peking University People's Hospital; Peking Union Medical College Hospital; Peking... and other collaborators

Recruiting

Chinese Colorectal Cancer Database (CCCD)

Rectal Cancer | Colonic Cancer | Prospective Studies

China
Jiangsu HengRui Medicine Co., Ltd.
307 Hospital of PLA; Peking University Cancer Hospital & Institute

Completed

A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies

Advanced Solid Malignancies

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Effect of 3D-printed Reconstruction System in Size of Left DLT

Cancer of Lung | Lung Isolation
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally Invasive Esophagectomy

Postoperative Pneumonia | Postoperative Pulmonary Atelectasis | Postoperative Pulmonary Edema
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Gynecological Tumor

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute

Recruiting

Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC (ETNT)

Esophageal Squamous Cell Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer

Cervical Cancer

China
Sichuan Cancer Hospital and Research Institute

Recruiting

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Liver Diseases | Digestive System Neoplasms | Liver Neoplasms | Hepatocellular Carcinoma | Antineoplastic Agents | Molecular Mechanisms of Pharmacological Action | Protein Kinase Inhibitors | Sorafenib

China
Sichuan Cancer Hospital and Research Institute

Active, not recruiting

Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Sichuan Cancer Hospital and Research Institute

Unknown

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

Lung Cancer | Extensive-stage Small Cell Lung Cancer

China
Peking University Third Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Beijing... and other collaborators

Recruiting

Nutrition Sufficiency, Allergy Efficacy and Safety of Neocate Jr in Children With Food Protein Allergy

Cow Milk Allergy | Food Allergy in Children

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy (OSinEC)

Outcomes of Smoker and Drinker After Esophagectomy

China
Sichuan Cancer Hospital and Research Institute

Recruiting

MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer

HNSCC

China
Sichuan Cancer Hospital and Research Institute

Recruiting

The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma

HNSCC

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatment in Ovarian Cancer

Ovarian Cancer

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Cervical Cancer

China
Sichuan Cancer Hospital and Research Institute

Recruiting

Dose-painting Radiation for LA-NSCLC (DPRLC)

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage II

China
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Squamous Cell Carcinoma (pLINE)

Surgery | Neoadjuvant Therapy | Esophageal Squamous Cell Carcinoma

China

Clinical Trials Sponsored by Peking University Cancer Hospital and Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations